An interventional study of Lithotripsy using Flexible ureteroscope and Extracorporeal shock wave lithotripsy (ESWL) in Urolithiasis and Stone, Kidney, sponsored by Kafrelsheikh University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.
Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 57 studies in Kidney Calculi with a site in Egypt — 21 open to participants now, 23 under way, none of them phase 3. Kidney Calculi · Egypt.
Among the 57 studies in Kidney Calculi with a site in Egypt, this one is the 2nd largest by enrollment of the 52 interventional ones that give a count, is one of 6 that started in 2023, is one of 49 with no phase, and was the 47th registered.
510 studies on the registry are indexed under Kidney Calculi; 147 are open to participants now.
Browse Kidney Calculi studies →21 of the 57 studies in Kidney Calculi with a site in Egypt are open now. Recruiting first, the newest first:
Fayoum University Hospital · Sites in Egypt
Ages 6 mo–15 yrs
Beni-Suef University · Sites in Egypt
Ages 18+
Al-Azhar University · Sites in Egypt
Ages 18–70
Ain Shams University · Sites in Egypt
Ages 18–60
Helwan University · Sites in Egypt
Ages 18–70
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 88 Kidney Calculi studies recruiting now, 48 (55%) set no upper age limit and 23 (26%) stop at 75 or younger; 6 take children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
57 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 6 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 300 is above the median of 86 across 392 interventional studies indexed under Kidney Calculi.
Median enrollment 100 across the 52 interventional studies, 100 across the 5 observational. Of the 24 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 57 have an industry lead sponsor. The 10 most frequent:
Kafrelsheikh University is the lead sponsor of 305 studies on the registry; 122 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Kafrelsheikh University has 1 study filed under Kidney Calculi — fewer than ten, so there is no comparison to draw.
6 of the studies in Kidney Calculi with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07295860Mansoura UniversityFANS-FURS vs Suction Mini-PCNL for 2-3 cm Renal Stones: A Multicenter Randomized Trial | 2027-01-01 |
| NCT07749807Benha UniversityNebulized Glubran 2-Assisted Tubeless PCNL Versus Conventional PCNL | 2027-02-01 |
| NCT07516535Ain Shams UniversityDISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones | 2027-04-30 |
| NCT07939438Misr University for Science and TechnologyPostoperative Stenting After Flexible Ureteroscopy in Children With Upper Urinary Tract Stones | 2027-05-30 |
| NCT07689565Tanta UniversityStandard Versus Flexible and Navigable Suction Ureteral Access Sheath in Pediatric Flexible Ureterorenoscopy for Renal Stones < 2 cm | 2027-06-01 |
Add all 6 to your calendar (.ics) → With an account.
Among the 57 studies in Kidney Calculi with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study has been conducted in Urology department at Kafrelsheikh University Hospital between Feburary 2021 to December 2023. informed consent was taken from eligible patients and were randomized into three groups, Group A :Flexible ureteroscope (F-URS) group underwent holmium laser lithotripsy using flexible ureteroscopy (Boston® scientific (lithovue) while, Group B : extracorporeal shock wave lithotripsy (ESWL) group underwent electromagnetic extracorporeal shock wave lithotripsy (STORZ® MEDICAL Modulith SLX-F2 FD21, Germany) .Group C : Mini perc group underwent holmium laser lithotripsy using Karl® Storz MIP set.
510 studies on the registry are indexed under Kidney Calculi; 147 are open to participants now.
This study's enrollment of 300 is above the median of 86 across 392 interventional studies indexed under Kidney Calculi.
Browse Kidney Calculi studies →Kafrelsheikh University is the lead sponsor of 305 studies on the registry; 122 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Compared within Kidney Calculi, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Urolithiasis. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Flexible ureteroscope (F-URS) group underwent holmium laser lithotripsy using flexible ureteroscopy (Boston® scientific (lithovue)
Procedure: Lithotripsy using Flexible ureteroscope
extracorporeal shock wave lithotripsy (ESWL) group underwent electromagnetic extracorporeal shock wave lithotripsy (STORZ® MEDICAL Modulith SLX-F2 FD21, Germany)
Procedure: Extracorporeal shock wave lithotripsy (ESWL)
Mini perc group underwent holmium laser lithotripsy using Karl® Storz MIP set.
Procedure: holmium laser lithotripsy using Karl® Storz MIP
using Flexible ureteroscope and holmium laser lithotripsy to get high stone clearance rate
using extracorporeal shock wave lithotripsy (ESWL) to get high stone clearance rate
using holmium laser lithotripsy using Karl® Storz MIP set to get high stone clearance rate
stone free rate
no stone residual fragments or asymptomatic insignificant residual fragments less than or equal to 4 mm during patients follow up two weeks.
Time frame: two weeks from primary procedure
ssess operative time
assess operative time.in minutes
Time frame: during the procedure
Radiation time
Time of patient exposure for radiation in minutes
Time frame: during the procedure
Post operative complication
Complication may occur post operative complication like fever, sever pain
Time frame: Up to 48 hours
Ran from Feb 2023 to primary completion in Dec 2025, 34 months.
Of 183 non-industry interventional studies with no phase under Kidney Calculi, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's 34 months is close to that.
Counting every sponsor, half of 199 studies reached it within 26 months; a quarter within 12 and three quarters within 51.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 23, 2026: start Feb 2021 → Feb 2023, primary completion Dec 2023 → Dec 2025 and completion Dec 2023 → Dec 2025.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.